Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
about
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment.Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.Targeting neoantigens for cancer immunotherapyThe neoepitope landscape in pediatric cancers.T cell optimization for the treatment of pancreatic cancer.Inflammation as a driver and vulnerability of KRAS mediated oncogenesisObstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.KRAS mutation and Consensus Molecular Subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer.Neoantigen prediction and the need for validation.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients.Shared cancer neoantigens: Making private matters public.Recent advances in the biology and therapy of medullary thyroid carcinoma.Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?Emerging Therapies in the Management of Advanced-Stage Gastric Cancer
P2860
Q30832820-73252072-F090-42AE-8B31-52FF18C1E22CQ33913077-5AE9FD41-7A11-4EB5-AE0D-34F914BD4CE4Q37043492-95D2EE30-8ED0-4B95-BD76-C05FE7EDCC98Q37223669-ED70BD17-86CF-4467-8727-54FCAF18CCFFQ38601828-B933E2A1-8884-42A8-84E9-41BBC238E7F4Q38638035-A5F8CF4C-444C-400D-988F-CA96DD54BA7BQ38864070-7161C7A1-B9B4-4FA8-A66C-F6160A20E777Q39178061-25BCED6E-B70D-43EC-8F1D-1A53970E758AQ39418546-2DB892B3-D5FD-4672-A937-578BAF5A8A11Q41514095-AEEDEFA3-ABA4-4D6C-B453-870556958B62Q42778262-CD11AEE3-CAEA-4564-95E2-138AF0BA3A5BQ46969749-B6351794-6E70-4842-BE45-B7FE1B5D320AQ47109220-EEBDB72A-4EF9-43BE-8D4A-0658DA7ABEC5Q47133741-DB429E46-EB81-4214-AF9E-8E9B5DCD818DQ47226691-0EF0F2DC-11D8-4019-BDA0-6C69436C7D8CQ48246978-292AE83A-B13C-4998-9F91-3E6952D0F77FQ55240544-D096AD77-9867-46AC-94CA-5D662EBAF3CEQ57111080-17875A8C-1C81-4645-9789-9E0C947E22D1
P2860
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@ast
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@en
type
label
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@ast
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@en
prefLabel
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@ast
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@en
P2093
P2860
P1476
Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
@en
P2093
James C Yang
Kayla Griffith
Ken-ichi Hanada
Qiong J Wang
P2860
P304
P356
10.1158/2326-6066.CIR-15-0188
P577
2015-12-23T00:00:00Z